JP2023078418A5 - - Google Patents

Download PDF

Info

Publication number
JP2023078418A5
JP2023078418A5 JP2023049452A JP2023049452A JP2023078418A5 JP 2023078418 A5 JP2023078418 A5 JP 2023078418A5 JP 2023049452 A JP2023049452 A JP 2023049452A JP 2023049452 A JP2023049452 A JP 2023049452A JP 2023078418 A5 JP2023078418 A5 JP 2023078418A5
Authority
JP
Japan
Prior art keywords
tautomer
trifluoromethyl
alkyl
compound
pyrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023049452A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023078418A (ja
JP7698676B2 (ja
Filing date
Publication date
Priority claimed from JP2022529556A external-priority patent/JP7254246B2/ja
Application filed filed Critical
Publication of JP2023078418A publication Critical patent/JP2023078418A/ja
Publication of JP2023078418A5 publication Critical patent/JP2023078418A5/ja
Application granted granted Critical
Publication of JP7698676B2 publication Critical patent/JP7698676B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023049452A 2019-11-25 2023-03-27 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法 Active JP7698676B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962939821P 2019-11-25 2019-11-25
US62/939,821 2019-11-25
JP2022529556A JP7254246B2 (ja) 2019-11-25 2020-11-24 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法
PCT/US2020/062020 WO2021108408A1 (en) 2019-11-25 2020-11-24 Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022529556A Division JP7254246B2 (ja) 2019-11-25 2020-11-24 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法

Publications (3)

Publication Number Publication Date
JP2023078418A JP2023078418A (ja) 2023-06-06
JP2023078418A5 true JP2023078418A5 (cg-RX-API-DMAC7.html) 2023-11-20
JP7698676B2 JP7698676B2 (ja) 2025-06-25

Family

ID=73855555

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022529556A Active JP7254246B2 (ja) 2019-11-25 2020-11-24 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法
JP2023049452A Active JP7698676B2 (ja) 2019-11-25 2023-03-27 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022529556A Active JP7254246B2 (ja) 2019-11-25 2020-11-24 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法

Country Status (21)

Country Link
US (3) US11512097B2 (cg-RX-API-DMAC7.html)
EP (1) EP4065223A1 (cg-RX-API-DMAC7.html)
JP (2) JP7254246B2 (cg-RX-API-DMAC7.html)
KR (2) KR20230154292A (cg-RX-API-DMAC7.html)
CN (2) CN118161500A (cg-RX-API-DMAC7.html)
AR (1) AR120556A1 (cg-RX-API-DMAC7.html)
AU (1) AU2020392087B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022010054A2 (cg-RX-API-DMAC7.html)
CA (1) CA3162281A1 (cg-RX-API-DMAC7.html)
CL (2) CL2022001357A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022008690A2 (cg-RX-API-DMAC7.html)
CR (1) CR20220308A (cg-RX-API-DMAC7.html)
IL (1) IL293191B2 (cg-RX-API-DMAC7.html)
JO (1) JOP20220125A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022006281A (cg-RX-API-DMAC7.html)
PE (1) PE20231097A1 (cg-RX-API-DMAC7.html)
PH (1) PH12022551282A1 (cg-RX-API-DMAC7.html)
SA (1) SA522432710B1 (cg-RX-API-DMAC7.html)
TW (2) TWI867822B (cg-RX-API-DMAC7.html)
UY (1) UY38971A (cg-RX-API-DMAC7.html)
WO (1) WO2021108408A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11220510B2 (en) * 2018-04-09 2022-01-11 Incyte Corporation Pyrrole tricyclic compounds as A2A / A2B inhibitors
BR112022010054A2 (pt) 2019-11-25 2022-08-16 Amgen Inc Compostos heterocíclicos como inibidores de delta-5 dessaturase e métodos de uso
CN115557903A (zh) * 2022-09-27 2023-01-03 山东潍坊润丰化工股份有限公司 一种特草定的制备方法
TW202434254A (zh) 2022-11-23 2024-09-01 美商安進公司 選擇用於fads1調節劑治療的患者之方法

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3130633A1 (de) 1981-08-01 1983-02-17 Basf Ag, 6700 Ludwigshafen 7-amino-azolo(1,5-a)pyrimidine und diese enthaltende fungizide
JP2641443B2 (ja) 1986-04-07 1997-08-13 クミアイ化学工業株式会社 5H−1,3,4−チアジアゾロ〔3,2−a〕ピリミジン−5−オン誘導体及びこれを有効成分とする農園芸用殺菌剤
US6096753A (en) 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
IL130181A0 (en) 1996-12-05 2000-06-01 Amgen Inc Substituted pyrimidone and pyridone compounds and methods of use
KR20020045609A (ko) 1999-10-15 2002-06-19 추후기재 고나도트로핀-분비 호르몬 수용체 길항제 및 이와 관련된방법
US6537998B1 (en) * 1999-10-15 2003-03-25 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
AU2003238157A1 (en) 2002-06-18 2003-12-31 Sankyo Company, Limited Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof
JP2004107228A (ja) 2002-09-17 2004-04-08 Nippon Nohyaku Co Ltd 双環性ピリミジノン誘導体及びこれを有効成分とする除草剤
PE20051089A1 (es) 2004-01-22 2006-01-25 Novartis Ag Derivados de pirazolo [1,5-a] pirimidin-7-il-amina como inhibidores de quinasa de proteina
US20050222171A1 (en) 2004-01-22 2005-10-06 Guido Bold Organic compounds
WO2006067401A1 (en) 2004-12-24 2006-06-29 Astrazeneca Ab Heterocyclic compounds as ccr2b antagonists
CA2612585A1 (en) 2005-06-27 2007-01-04 Amgen Inc. Anti-inflammatory aryl nitrile compounds
EP1905238A4 (en) 2005-07-18 2009-04-22 Samsung Electronics Co Ltd Video coding method and apparatus for reducing mismatch between encoder and decoder
BRPI0614158A2 (pt) 2005-07-27 2016-11-22 Basf Ag compostos, processo para reparar compostos, agente fungicida, semente, e, processo para combater fungos nocivos fitopatogênicos
CN101228168A (zh) 2005-07-27 2008-07-23 巴斯福股份公司 6-苯基吡唑并嘧啶-7-基胺杀真菌剂
US20080200480A1 (en) 2005-07-27 2008-08-21 Basf Aktiengesellschaft Fungicidal 6-Phenyltriazolopyrimidinylamines
TWI421078B (zh) 2005-10-06 2014-01-01 Merck Sharp & Dohme 關卡激酶抑制劑及其用途
BRPI0717134A2 (pt) 2006-09-28 2013-10-15 Novartis Ag Derivados de pirazol [1,5-a] pirimidina e seu uso de terapêutico
CA2665476A1 (en) 2006-10-05 2008-04-10 Cv Therapeutics, Inc. Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
WO2008057601A2 (en) 2006-11-08 2008-05-15 The Rockefeller University Organic compounds
WO2008089310A2 (en) 2007-01-18 2008-07-24 Lexicon Pharmaceuticals, Inc. Delta 5 desaturase inhibitors for the treatment of obesity
WO2008089307A2 (en) 2007-01-18 2008-07-24 Lexicon Pharmaceuticals, Inc. Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer
BRPI0806347A2 (pt) 2007-01-19 2011-09-06 Basf Se misturas fungicidas, agente fungicida, método para combater fungos nocivos fitopagênicos, semente, e, processo para preparar um agente
EP2131658A2 (en) 2007-01-30 2009-12-16 Basf Se Method for improving plant health
WO2008116730A1 (de) 2007-03-23 2008-10-02 Basf Se Wirkstoffkombinationen
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
US20090253704A1 (en) * 2008-04-04 2009-10-08 Dmitry Koltun PYRROLOTRIAZINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
US8119647B2 (en) 2008-04-23 2012-02-21 Glenmark Pharmaceuticals S.A. Fused pyrimidineone compounds as TRPV3 modulators
US20100099561A1 (en) 2008-10-15 2010-04-22 E.I. Du Pont De Nemours And Company Heterobicyclic alkylthio-bridged isoxazolines
UY32395A (es) * 2009-01-27 2010-08-31 Takeda Pharmaceutical Compuesto con anillo fusionado y su uso
PL2448938T3 (pl) 2009-06-29 2014-11-28 Incyte Holdings Corp Pirymidynony jako inhibitory PI3K
WO2011114148A1 (en) * 2010-03-17 2011-09-22 Astrazeneca Ab 4h- [1, 2, 4] triazolo [5, 1 -b] pyrimidin-7 -one derivatives as ccr2b receptor antagonists
WO2012011592A1 (ja) 2010-07-23 2012-01-26 武田薬品工業株式会社 複素環化合物およびその用途
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
US8952012B2 (en) 2012-05-24 2015-02-10 Colorado State University Research Foundation Inhibition of delta-6 desaturase for the treatment of cardiometabolic disease
CN105980386B (zh) 2013-03-13 2021-08-13 基因泰克公司 吡唑并化合物及其用途
WO2015035062A1 (en) 2013-09-05 2015-03-12 Genentech, Inc. Antiproliferative compounds
WO2015064714A1 (ja) 2013-10-31 2015-05-07 国立大学法人東京大学 オートタキシン阻害活性を有する1-置換イミダゾピリミジノン誘導体
WO2015135094A1 (en) 2014-03-13 2015-09-17 Genentech, Inc. Therapeutic compounds and uses thereof
WO2015163339A1 (ja) 2014-04-23 2015-10-29 田辺三菱製薬株式会社 新規二環性または三環性複素環化合物
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
JP6791717B2 (ja) 2015-10-22 2020-11-25 田辺三菱製薬株式会社 医薬組成物
JP2017091808A (ja) 2015-11-10 2017-05-25 株式会社フジクラ 酸化物超電導線材の製造方法及び超電導コイルの製造方法
WO2017112678A1 (en) 2015-12-21 2017-06-29 Rima Mcleod Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases
KR102411150B1 (ko) 2016-08-31 2022-06-21 아지오스 파마슈티컬스 아이엔씨. 세포 대사 과정의 억제제
WO2018039972A1 (en) * 2016-08-31 2018-03-08 Agios Pharmaceuticals, Inc. Inhibitors of cellular metabolic processes
CN106749271B (zh) 2016-12-07 2019-04-05 青岛科技大学 一类[1,2,4]-三氮唑并[1,5-a]嘧啶酮类杂环化合物、其制备方法及其用途
WO2018213365A1 (en) 2017-05-15 2018-11-22 Dana-Farber Cancer Institute, Inc. Compounds for treating dengue virus infection and other viral infections
WO2018229683A1 (en) 2017-06-15 2018-12-20 Novartis Ag 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases
US10738056B2 (en) 2017-09-15 2020-08-11 Aduro Biotech Inc. Pyrazolopyrimidinone compounds and uses thereof
BR112022010054A2 (pt) 2019-11-25 2022-08-16 Amgen Inc Compostos heterocíclicos como inibidores de delta-5 dessaturase e métodos de uso

Similar Documents

Publication Publication Date Title
JP2023078418A5 (cg-RX-API-DMAC7.html)
JP2024532733A (ja) 複素環式化合物及び使用方法
RU2424242C2 (ru) Азолопиримидины в качестве ингибиторов активности каннабиноидного рецептора 1
JP2024532735A (ja) 複素環式化合物及び使用方法
HRP20240935T1 (hr) Heterociklični i heteroaril spojevi za liječenje huntingtonove bolesti
JP2015511245A5 (cg-RX-API-DMAC7.html)
JP2017518326A5 (cg-RX-API-DMAC7.html)
JP2025508702A (ja) キナゾリン化合物、及び変異krasタンパク質の阻害剤としてのその使用
US20210163417A1 (en) Isoquinolines as inhibitors of hpk1
JPWO2020005873A5 (cg-RX-API-DMAC7.html)
RU2017121278A (ru) Триазоло-пиразинильные производные, применимые в качестве растворимых активаторов гуанилатциклазы
HRP20120105T1 (hr) Aminoheterociklički spojevi
RU2012136907A (ru) Модуляторы гамма-секретазы
JP2013523884A5 (cg-RX-API-DMAC7.html)
JP2017524734A5 (cg-RX-API-DMAC7.html)
JP2011500774A5 (cg-RX-API-DMAC7.html)
JP2003531210A5 (cg-RX-API-DMAC7.html)
RU2015131148A (ru) СОЕДИНЕНИЯ, ГЕТЕРОБИЦИКЛО-ЗАМЕЩЕННЫЕ-[1, 2, 4]ТРИАЗОЛО[1, 5c]ХИНАЗОЛИН-5-АМИНА, ОБЛАДАЮЩИЕ СВОЙСТВАМИ А2А АНТАГОНИСТОВ
JP2016504363A5 (cg-RX-API-DMAC7.html)
HUE028019T2 (en) Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity
JP2025533831A (ja) Kras g12c変異タンパク質のテザー型複素環式阻害剤及びその使用
JP2016537384A5 (cg-RX-API-DMAC7.html)
WO2022093856A1 (en) Heterocyclic spiro compounds and methods of use
JP2016520118A5 (cg-RX-API-DMAC7.html)
RU2017141077A (ru) Ингибитор некоторых протеинкиназ